Solid-phase immunoassay is a commonly used immunological technique in many clinical and research laboratories. It is known that proteins will adsorb to a solid surface such as polystyrene. Many studies have also indicated that surface modifications such as the introduction of different functional groups onto the polystyrene surface will enhance the overall protein-binding properties of the plastic polymer (1 ) . Nevertheless, the increased binding also means increased nonspecific binding, producing higher background signals.
The currently available polystyrene surfaces work well for most protein antigens. However, these polystyrene surfaces are not adequate for the measurement of all antigenic substances. Certain antigenic lipids are not easily detected and measured using these surfaces (2 ) . A commonly used diagnostic test for anti-phospholipid antibodies (aPLs) is an ELISA using cardiolipin, an anionic phospholipid, as the antigen in the solid-phase immunoassay (3 ) .
aPLs are antibodies associated with the clinical syndrome of thrombosis and recurrent midtrimester fetal death and other, less common manifestations, termed antiphospholipid syndrome (4 ) . aPLs are also detected in patients with systemic lupus erythematosus and related autoimmune disorders (5) (6) (7) .
There are numerous critical variables for anticardiolipin assays. Critical factors that can influence ELISA results include the amount of phospholipids coated on the surface, the solvent for the phospholipids, choice of blocking agents and serum diluent, incubation temperature, and the type of microwell plates (8 -10 ) . To develop a solidphase immunoassay optimized for phospholipids, we examined various modified polystyrene surfaces for the ability to bind protein and phospholipids, including cardiolipin.
The following reagents were obtained from Sigma: cardiolipin (diphosphatidylglycerol), sodium salt from beef heart, 4.8 g/L in ethanol; o-phenylenediamine dihydrochloride (OPD), 30-mg tablets; p-nitrophenyl phosphate, disodium; and diethanolamine, ACS reagent grade. Nitrobenzoxadizole (NBD)-labeled 1-palmitoyl-2-[6-(7nitro-2-1,3-benzoxadiazol-4-y)]-sn-glycerol 3-phosphoserine (sodium salt), M r 796.81, 1 g/L in chloroform; and 1,2-dioleoyl-sn-glycerol-3-[phospho-l-serine] (sodium salt), M r 810.03, 10 g/L in chloroform were obtained from Avanti Polar Lipids. Acridine orange 10 nonyl bromide (M r 472.51) was obtained from Molecular Probes. All other laboratory chemicals were analytical grade and were from Sigma and Mallinckrodt.
Polyclonal rabbit anti-sheep (18 g/L) and rabbit antihuman ␣ 1 -fetoprotein-horseradish peroxidase (HRP) conjugate (1.3 g/L) were purchased from Dako. Lyophilized positive serum samples for IgG anti-cardiolipin antibod-ies (aCLs) were obtained from Louisville APL Diagnostics. Alkaline phosphatase-conjugated goat anti-human IgG (␥-chain specific) affinity-isolated antibody and adult bovine serum were obtained from Sigma.
For the protein binding assay, the 96-well plates were coated (200 L per well) with an antibody mixture solution containing 3600 g/L rabbit anti-sheep IgG and 33 g/L rabbit anti-human ␣ 1 -fetoprotein-HRP in 0.05 mol/L carbonate buffer, pH 9.6. The plates were sealed with Nunc™ sealing tape and incubated overnight in the dark at room temperature. The plates were washed three times with a washing buffer [0.15 mol/L phosphatebuffered saline (PBS), pH 7.2, containing 0.2 mol/L NaCl and 0.5 mL/L Triton X-100]. The washed plates were incubated with a substrate solution (200 L per well) consisting of 0.6 g/L OPD and 0.5 mL/L H 2 O 2 (300 g/L) in 0.1 mol/L citrate phosphate buffer, pH 5.0. The colorimetric reaction was stopped by the addition of 2 mol/L H 2 SO 4 (150 L per well). Absorbance at 490 nm was determined using a microplate reader.
For the cardiolipin binding assay, cardiolipin diluted in ethanol was coated onto the 96-well microplate by evaporation overnight at 4°C. The plate was washed three times with PBS. One hundred microliters of a fluorescent dye, 10-N-nonyl-acridine orange (15 mol/L), was added to each well. The plate was incubated at room temperature under reduced light. Nonbound dye was removed by washing the plate with PBS. Fluorescence was detected by a fluorescence microplate reader using two filter sets: filter set 1, excitation at 485 nm, emission at 530 nm; and filter set 2, excitation at 485 nm, emission at 645 nm.
For the phospholipid binding assay, NBD-labeled phosphatidylserine and nonlabeled phosphatidylserine were mixed at a ratio of 1:20 in chloroform:methanol (1:4, by volume) in a glass tube. Different volumes (15-90 L per well) of the mixed phosphatidylserine solution were dispensed into a 96-well plate. The solutions in the wells were dried under nitrogen to minimize oxidation. The plate was washed three times with PBS, and 100 L of PBS was then added to each well. Fluorescence was detected by a fluorescence plate reader with excitation at 485 nm and emission at 530 nm.
For the anticardiolipin ELISA, cardiolipin (50 mg/L in alcohol) was immobilized on a 96-well plate by evaporation overnight at 4°C. The wells were blocked with bovine serum albumin (BSA) buffer (PBS containing 20 g/L BSA) and incubated for 1 h at 4°C. The plate was washed three times with PBS. Human sera positive for aCLs were added to the wells (100 L per well) and incubated at 4°C for 2 h. After incubation, the plate was washed three times with PBS. A secondary antibody (goat anti-human IgG-alkaline phosphatase conjugate diluted 1:1000 in PBS with 100 mL/L adult bovine serum) was added and incubated for 1 h at 4°C. The plate was washed with PBS, and buffered substrate (1 g/L pnitrophenyl phosphate in diethanolamine buffer) was added. The plate was sealed with tape and incubated for 1 h at room temperature under reduced light. The colorimetric reaction was stopped by the addition of 3 mol/L NaOH, and the absorbance at 405 nm was measured by a microplate reader.
We compared the protein binding characteristics of polystyrene plates with nonmodified surfaces and plates with surfaces modified by two different processes. Nunc plates (96-well) with three different surfaces, nonmodi-fied, MultiSorp TM , and MaxiSorp TM , were incubated with an antibody mixture solution containing rabbit anti-sheep IgG and rabbit anti-human ␣ 1 -fetoprotein conjugated with HRP as described above. Bound IgG was detected by the colorimetric reaction of OPD and H 2 O 2 with HRP. Absorbance measurements at 490 nm (A 490 nm ) reflected Clinical Chemistry 46, No. 9, 2000 attachment of IgG on the surfaces. The mean A 490 nm (n ϭ 96) was 11 077.83 Ϯ 409.51 for plates with the nonmodified surface, 857.04 Ϯ 330.45 for plates with the MultiSorp surface, and 16 630.98 Ϯ 588.46 for plates with the Maxi-Sorp surface. A comparison of the absorbance readings of the three surfaces clearly indicated that the MultiSorp surface has a low affinity for IgG, i.e., at the given coating concentration and equal coating time as described above, less IgG was bound to the MultiSorp surface compared with the other two surfaces.
To explore the binding capability of the modified surfaces for molecules other than IgG, we determined the binding of phosphatidylserine, an anionic phospholipid, on these surfaces. Acyl chain-labeled, fluorescent NBDphosphatidylserine was used to measure phospholipid binding to plates with nonmodified surfaces and plates with MultiSorp and MaxiSorp surfaces. Fluorescent NBDlabeled phosphatidylserine was mixed with nonlabeled phosphatidylserine at a ratio of 1:20, diluted in chloroform:methanol (1:4, by volume) and dried under nitrogen onto plates with different surfaces as described above. Relative fluorescence was measured using a fluorescent plate reader. As shown in Fig. 1A , plates with MultiSorp and MaxiSorp surfaces demonstrated a higher capacity for binding phosphatidylserine.
Because cardiolipin, a negatively charged phospholipid, is commonly used as the solid-phase antigen in most diagnostic ELISAs for aPLs, we measured the binding of cardiolipin on the modified surfaces. Fig. 1B shows the cardiolipin binding data for these surfaces. Cardiolipin binding on the solid surfaces was detected by the fluorescent dye 10-N-nonyl acridine orange as described above. 10-N-Nonyl acridine orange has been reported to interact specifically with cardiolipin isolated from mitochondria and whole cells with a stoichiometry of 2:1. Upon contact with cardiolipin, the dye forms dimers, producing a shift in emission fluorescence from 525 nm to 640 nm (11, 12 ) . In Fig. 1B , the amount of cardiolipin bound to the solid surfaces was quantified by the red emission wavelength (640 nm) of the dye after unbound dye was removed by washing. A slightly increased binding of cardiolipin on both modified surfaces was observed, as shown in Fig. 1B .
To demonstrate that cardiolipin immobilized on the MultiSorp surface retained an active functional configuration, we performed an anticardiolipin ELISA using a plate with the modified surface. The ELISA results are shown in Table 1 . These results indicate that cardiolipin directly bound on the modified surface contains an epitope that is recognized by aCLs in human serum. The bound cardiolipin is not recognized by IgG in rabbit serum. It is also interesting to note that nonspecific proteins such as BSA and other proteins in adult bovine serum did not interact with cardiolipin on this modified surface, thus providing very low background in the ELISA.
In summary, we learned that a surface modification process can both enhance the binding of anionic phospholipids and reduce the binding of IgG on a polystyrene surface. The resulting surface is ideal for phospholipidbased immunoassays and may also be useful for other assays requiring low protein binding.
We thank Erika Tracy for technical assistance and Tony Chin for assistance in graphics.
